Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
105,632,895
-
Number of holders
-
399
-
Total 13F shares, excl. options
-
81,723,093
-
Shares change
-
+1,067,459
-
Total reported value, excl. options
-
$9,359,752,457
-
Value change
-
+$62,411,602
-
Put/Call ratio
-
150%
-
Number of buys
-
202
-
Number of sells
-
-202
-
Price
-
$114.52
Significant Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q2 2023
525 filings reported holding SRPT - Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q2 2023.
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) has 399 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 81,723,093 shares
of 105,632,895 outstanding shares and own 77% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (8,531,479 shares), BlackRock Inc. (5,503,466 shares), JANUS HENDERSON GROUP PLC (5,447,667 shares), Avoro Capital Advisors LLC (4,627,888 shares), JPMORGAN CHASE & CO (4,404,093 shares), WELLINGTON MANAGEMENT GROUP LLP (3,855,102 shares), EcoR1 Capital, LLC (3,660,798 shares), Bank of New York Mellon Corp (2,432,768 shares), STATE STREET CORP (1,913,732 shares), and FMR LLC (1,803,828 shares).
This table shows the top 399 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.